Fructose: a modulator of intestinal barrier function and hepatic health?
- Authors
- Type
- Published Article
- Journal
- European Journal of Nutrition
- Publisher
- Springer-Verlag
- Publication Date
- Dec 01, 2023
- Volume
- 62
- Issue
- 8
- Pages
- 3113–3124
- Identifiers
- DOI: 10.1007/s00394-023-03232-7
- PMID: 37596353
- Source
- Medline
- Keywords
- Language
- English
- License
- Unknown
Abstract
Consumption of fructose has repeatedly been discussed to be a key factor in the development of health disturbances such as hypertension, diabetes type 2, and non-alcoholic fatty liver disease. Despite intense research efforts, the question if and how high dietary fructose intake interferes with human health has not yet been fully answered. Studies suggest that besides its insulin-independent metabolism dietary fructose may also impact intestinal homeostasis and barrier function. Indeed, it has been suggested by the results of human and animal as well as in vitro studies that fructose enriched diets may alter intestinal microbiota composition. Furthermore, studies have also shown that both acute and chronic intake of fructose may lead to an increased formation of nitric oxide and a loss of tight junction proteins in small intestinal tissue. These alterations have been related to an increased translocation of pathogen-associated molecular patterns (PAMPs) like bacterial endotoxin and an induction of dependent signaling cascades in the liver but also other tissues. In the present narrative review, results of studies assessing the effects of fructose on intestinal barrier function and their impact on the development of health disturbances with a particular focus on the liver are summarized and discussed. © 2023. The Author(s).
